NOVA2 Antikörper
Kurzübersicht für NOVA2 Antikörper (ABIN7074810)
Target
Alle NOVA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Kreuzreaktivität
- Maus, Ratte
- 
                                            Aufreinigung
- Affinity purification
- 
                                            Immunogen
- KLH conjugated Synthetic peptide corresponding to Human Nova2
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- WB (H,M,R) 1:1000-1:2000, IHC/IF (H,M,R) 1:200-1:400
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- PBS, pH 7.4, 0.02 % sodium azide
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C
 
- 
                                            
- 
    - NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
- 
                                            Andere Bezeichnung
- Nova2
- 
                                            Hintergrund
- NOVA2 (also named as ANOVA and NOVA3) is members of a superfamily of protein regulators of RNA metabolism in neurons. It regulates RNA splicing or metabolism in a specific subset of developing neurons. NOVA2 binds single strand RNA.
- 
                                            Molekulargewicht
- 58 kDa
- 
                                            Gen-ID
- 4858
- 
                                            NCBI Accession
- NP_002507
- 
                                            UniProt
- Q9UNW9
 Target
- 
                    
 
                                     
                                     
                                    